| Literature DB >> 31125103 |
Kara A Rothenberg1, Jordan R Stern1,2, Elizabeth L George1, Amber W Trickey1, Arden M Morris1, Daniel E Hall3,4,5, Jason M Johanning6, Mary T Hawn1, Shipra Arya1,2.
Abstract
Importance: Ambulatory surgery in geriatric populations is increasingly prevalent. Prior studies have demonstrated the association between frailty and readmissions in the inpatient setting. However, few data exist regarding the association between frailty and readmissions after outpatient procedures. Objective: To examine the association between frailty and 30-day unplanned readmissions after elective outpatient surgical procedures as well as the potential mediation of surgical complications. Design, Setting, and Participants: In this retrospective cohort study of elective outpatient procedures from 2012 and 2013 in the National Surgical Quality Improvement Program (NSQIP) database, 417 840 patients who underwent elective outpatient procedures were stratified into cohorts of individuals with a length of stay (LOS) of 0 days (LOS = 0) and those with a LOS of 1 or more days (LOS ≥ 1). Statistical analysis was performed from June 1, 2018, to March 31, 2019. Exposure: Frailty, as measured by the Risk Analysis Index. Main Outcomes and Measures: The main outcome was 30-day unplanned readmission.Entities:
Mesh:
Year: 2019 PMID: 31125103 PMCID: PMC6632151 DOI: 10.1001/jamanetworkopen.2019.4330
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Patient Demographics
| Characteristic | LOS = 0 (n = 321 104 [76.8%]) | LOS ≥ 1 (n = 96 736 [23.2%]) | ||||
|---|---|---|---|---|---|---|
| Nonfrail (n = 313 025 [97.5%]) | Frail (n = 8079 [2.5%]) | Nonfrail (n = 93 695 [96.9%]) | Frail (n = 3041 [3.1%]) | |||
| Age, mean (SD), y | 35.0 (15.8) | 64.9 (15.5) | <.001 | 37.2 (15.0) | 63.2 (17.5) | <.001 |
| Female sex, No. (%) | 176 083 (56.3) | 2527 (31.3) | <.001 | 67 607 (72.2) | 1290 (42.4) | <.001 |
| Diabetes, No. (%) | ||||||
| Insulin dependent | 9897 (3.2) | 1012 (12.5) | <.001 | 4049 (4.3) | 318 (10.5) | <.001 |
| Non–insulin dependent | 22 271 (7.1) | 950 (11.8) | 8551 (9.1) | 370 (12.2) | ||
| Hypertension, No. (%) | 107 807 (34.4) | 5673 (70.2) | <.001 | 39 535 (42.2) | 2099 (69.0) | <.001 |
| Congestive heart failure, No. (%) | 287 (0.1) | 315 (3.9) | <.001 | 129 (0.1) | 119 (3.9) | <.001 |
| Coronary artery disease, No. (%) | 1522 (0.5) | 156 (1.9) | <.001 | 551 (0.6) | 77 (2.5) | <.001 |
| Disseminated cancer, No. (%) | 8 (<0.01) | 1350 (16.7) | <.001 | 11 (0.01) | 792 (26.0) | <.001 |
| COPD, No. (%) | 7138 (2.3) | 751 (9.3) | <.001 | 3014 (3.2) | 278 (9.2) | <.001 |
| Current smoker, No. (%) | 54 262 (17.3) | 642 (8.0) | <.001 | 16 175 (17.3) | 239 (7.9) | <.001 |
| Preoperative hematocrit, No. (%) | ||||||
| Q1: 43.2%-60.0% | 57 718 (18.4) | 875 (10.8) | <.001 | 16 572 (17.7) | 332 (10.9) | <.001 |
| Q2: 40.6%-43.1% | 52 084 (16.6) | 1015 (12.6) | 18 904 (20.2) | 471 (15.5) | ||
| Q3: 37.9%-40.5% | 54 860 (17.5) | 1470 (18.2) | 22 402 (23.9) | 623 (20.5) | ||
| Q4: 8.0%-37.8% | 47 995 (15.3) | 3604 (44.6) | 21 569 (23.0) | 1360 (44.7) | ||
| Unknown or missing | 100 368 (32.1) | 1115 (13.8) | 14 248 (15.2) | 255 (8.4) | ||
| ASA Classification, No. (%) | ||||||
| I: No disturbance | 55 693 (17.8) | 66 (0.8) | <.001 | 7301 (7.8) | 18 (0.6) | <.001 |
| II: Mild disturbance | 178 818 (57.1) | 1704 (21.1) | 51 917 (55.4) | 635 (20.9) | ||
| III: Severe disturbance | 73 203 (23.4) | 5016 (62.1) | 32 429 (34.6) | 1990 (65.4) | ||
| IV: Life threatening | 3593 (1.2) | 1171 (14.5) | 1801 (1.9) | 377 (12.4) | ||
| Unknown or missing | 1718 (0.6) | 122 (1.5) | 247 (0.3) | 21 (0.7) | ||
| Corticosteroid use, No. (%) | 6252 (2.0) | 445 (5.5) | <.001 | 2445 (2.6) | 190 (6.3) | <.001 |
| Bleeding disorder, No. (%) | 5337 (1.7) | 8079 (9.2) | <.001 | 2227 (2.4) | 314 (10.3) | <.001 |
Abbreviations: ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; LOS, length of stay in days; Q, quartile.
Complications Within 30 Days
| Complication | LOS = 0 (n = 321 104 [76.8%]) | LOS ≥ 1 (n = 96 736 [23.2%]) | ||||
|---|---|---|---|---|---|---|
| Nonfrail (n = 313 025 [97.5%]) | Frail (n = 8079 [2.5%]) | Nonfrail (n = 93 695 [96.9%]) | Frail (n = 3041 [3.1%]) | |||
| Minor, No. (%) | ||||||
| Superficial surgical site infection | 2025 (0.7) | 43 (0.5) | .20 | 763 (0.8) | 34 (1.1) | .07 |
| DVT or thromboembolism | 349 (0.1) | 18 (0.2) | .003 | 132 (0.1) | 13 (0.4) | <.001 |
| Renal insufficiency | 61 (0.02) | 14 (0.2) | <.001 | 29 (0.03) | 8 (0.3) | <.001 |
| Urinary tract infection | 1378 (0.4) | 131 (1.6) | <.001 | 819 (0.9) | 68 (2.2) | <.001 |
| Bleeding requiring transfusion | 133 (0.04) | 28 (0.4) | <.001 | 575 (0.6) | 69 (2.3) | <.001 |
| Any minor complication | 3896 (1.2) | 230 (2.9) | <.001 | 2265 (2.4) | 181 (6.0) | <.001 |
| Major, No. (%) | ||||||
| SSI | ||||||
| Deep incisional | 440 (0.1) | 22 (0.3) | .002 | 211 (0.2) | 4 (0.1) | .43 |
| Organ space | 376 (0.1) | 13 (0.2) | .30 | 314 (0.3) | 15 (0.5) | .14 |
| Wound disruption | 283 (0.09) | 14 (0.2) | .02 | 175 (0.2) | 10 (0.3) | .08 |
| Pneumonia | 213 (0.07) | 50 (0.6) | <.001 | 136 (0.2) | 21 (0.7) | <.001 |
| Unplanned intubation | 91 (0.03) | 25 (0.3) | <.001 | 94 (0.1) | 5 (0.2) | .24 |
| Pulmonary embolism | 181 (0.06) | 10 (0.1) | .02 | 107 (0.1) | 10 (0.3) | .001 |
| Ventilator >48 h | 37 (0.01) | 4 (0.05) | .02 | 45 (0.05) | 4 (0.1) | .07 |
| Acute renal failure | 46 (0.01) | 10 (0.1) | <.001 | 29 (0.03) | 5 (0.2) | .004 |
| Stroke or CVA | 43 (0.01) | 20 (0.3) | <.001 | 34 (0.04) | 6 (0.2) | <.001 |
| Cardiac arrest requiring CPR | 37 (0.01) | 12 (0.2) | <.001 | 19 (0.02) | 1 (0.03) | .47 |
| Myocardial infarction | 87 (0.03) | 20 (0.3) | <.001 | 43 (0.05) | 11 (0.4) | <.001 |
| Sepsis | 351 (0.1) | 47 (0.6) | <.001 | 216 (0.2) | 22 (0.7) | <.001 |
| Septic shock | 62 (0.02) | 26 (0.3) | <.001 | 46 (0.05) | 7 (0.2) | <.001 |
| Return to operating room | 2908 (0.9) | 213 (2.6) | <.001 | 1560 (1.7) | 88 (2.9) | <.001 |
| Any major complication | 4242 (1.4) | 381 (4.7) | <.001 | 2402 (2.6) | 155 (5.1) | <.001 |
| Any complication, No. (%) | 7659 (2.5) | 555 (6.9) | <.001 | 4300 (4.6) | 297 (9.8) | <.001 |
| Unplanned readmission, No. (%) | 5814 (1.9) | 669 (8.3) | <.001 | 3018 (3.2) | 258 (8.5) | <.001 |
Abbreviations: CPR, cardiopulmonary resuscitation; CVA, cerebrovascular accident; DVT, deep venous thrombosis; LOS, length of stay in days; SSI, surgical site infection.
Figure 1. Thirty-Day Unplanned Readmissions by Frailty and Complication Status
Regression Models Demonstrating the Adjusted Relative Risk for Unplanned Readmission
| Model | Adjusted Relative Risk (95% CI) | |
|---|---|---|
| LOS = 0 (n = 321 104 [76.8%]) | LOS ≥ 1 (n = 96 736 [23.2%]) | |
| Frailty | 2.1 (2.0-2.3) | 1.8 (1.6-2.1) |
| Diabetes [reference: none] | ||
| Insulin dependent | 1.6 (1.4-1.7) | 1.3 (1.1-1.4) |
| Non–insulin dependent | 1.0 (1.0-1.1) | 1.0 (0.9-1.1) |
| Hypertension | 1.1 (1.1-1.2) | 1.1 (1.0-1.2) |
| Coronary artery disease | 1.1 (0.9-1.4) | 1.0 (0.7-1.4) |
| COPD | 1.5 (1.4-1.7) | 1.3 (1.1-1.5) |
| Current smoker | 1.2 (1.1-1.3) | 1.3 (1.1-1.4) |
| Hematocrit quartiles [reference: 1: 43.2%-60.0%} | ||
| 2: 40.6%-43.1% | 1.1 (1.0-1.2) | 1.0 (0.9-1.1) |
| 3: 37.9%-40.5% | 1.2 (1.1-1.3) | 1.0 (0.9-1.1) |
| 4: 8.0%-37.8% | 1.7 (1.6-1.9) | 1.2 (1.1-1.4) |
| Missing | 0.9 (0.8-1.0) | 0.9 (0.8-1.0) |
| ASA classification [reference: I] | ||
| II | 1.5 (1.3-1.6) | 1.3 (1.1-1.5) |
| III | 2.4 (2.2-2.7) | 1.9 (1.6-2.3) |
| IV | 3.4 (2.9-4.0) | 2.9 (2.3-3.7) |
| Missing | 1.8 (1.3-2.5) | 2.6 (1.6-4.2) |
| Corticosteroid use | 1.8 (1.6-2.0) | 1.5 (1.3-1.8) |
| Bleeding disorder | 1.6 (1.4-1.8) | 1.4 (1.2-1.6) |
| Frailty | 1.5 (1.3-1.6) | 1.5 (1.3-1.7) |
| Complication [reference: none] | ||
| Minor | 10.8 (9.8-11.9) | 6.0 (5.3-6.9) |
| Major | 42.2 (40.0-44.5) | 27.0 (25.1-29.1) |
| Diabetes [reference: none] | ||
| Type 1 | 1.1 (1.0-1.2) | 1.1 (1.0-1.3) |
| Type 2 | 1.0 (1.0-1.1) | 1.0 (0.9-1.1) |
| Hypertension | 1.1 (1.0-1.2) | 1.1 (1.0-1.2) |
| Coronary artery disease | 1.1 (0.9-1.4) | 1.0 (0.7-1.4) |
| COPD | 1.3 (1.2-1.4) | 1.2 (1.0-1.3) |
| Current smoker | 1.1 (1.0-1.2) | 1.1 (1.0-1.2) |
| Hematocrit quartiles [reference: 1: 43.2%-60.0%] | ||
| 2: 40.6%-43.1% | 1.0 (1.0-1.1) | 1.2 (1.0-1.5) |
| 3: 37.9%-40.5% | 1.1 (1.0-1.2) | 1.6 (1.4-2.0) |
| 4: 8.0%-37.8% | 1.4 (1.3-1.5) | 1.9 (1.5-2.4) |
| Missing | 0.9 (0.8-0.9) | 2.0 (1.2-3.2) |
| ASA classification [reference: I] | ||
| II | 1.4 (1.2-1.5) | 1.2 (1.0-1.5) |
| III | 1.9 (1.7-2.1) | 1.6 (1.4-2.0) |
| IV | 2.2 (1.9-2.5) | 1.9 (1.5-2.4) |
| Missing | 1.4 (1.0-1.9) | 2.0 (1.2-3.2) |
| Corticosteroid use | 1.5 (1.3-1.7) | 1.3 (1.1-1.5) |
| Bleeding disorder | 1.2 (1.1-1.4) | 1.2 (1.0-1.4) |
Abbreviations: ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; LOS, length of stay in days.
Figure 2. Mediation Analysis
LOS indicates length of stay.